{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:14:07Z","timestamp":1783710847450,"version":"3.55.0"},"reference-count":41,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,8]]},"DOI":"10.14218\/jcth.2020.00125","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T23:06:56Z","timestamp":1615158416000},"page":"000-000","source":"Crossref","is-referenced-by-count":3,"title":["Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis"],"prefix":"10.14218","volume":"000","author":[{"given":"Mengdi","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"key20210307230651_JCTH-D-20-00125-b1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"key20210307230651_JCTH-D-20-00125-b2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20210307230651_JCTH-D-20-00125-b3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.6002\/ect.2012.0085","article-title":"Management of recurrent hepatocellular carcinoma in liver transplant recipients: a systematic review","volume":"10","author":"Rubin","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"key20210307230651_JCTH-D-20-00125-b4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4254\/wjh.v12.i12.1239","article-title":"Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature","volume":"12","author":"Campigotto","year":"2020","journal-title":"World J Hepatol"},{"key":"key20210307230651_JCTH-D-20-00125-b5","doi-asserted-by":"crossref","first-page":"e1808","DOI":"10.1097\/MD.0000000000001808","article-title":"When to perform surgical resection or radiofrequency ablation for early hepatocellular carcinoma?: A nomogram-guided treatment strategy","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key20210307230651_JCTH-D-20-00125-b6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.2017162756","article-title":"Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: Systematic review of randomized controlled trials with meta-analysis and trial sequential analysis","volume":"287","author":"Xu","year":"2018","journal-title":"Radiology"},{"key":"key20210307230651_JCTH-D-20-00125-b7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00330-017-5039-x","article-title":"Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods?","volume":"28","author":"Korkusuz","year":"2018","journal-title":"Eur Radiol"},{"key":"key20210307230651_JCTH-D-20-00125-b8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ejso.2010.08.133","article-title":"Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results","volume":"36","author":"Peng","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"key20210307230651_JCTH-D-20-00125-b9","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"key20210307230651_JCTH-D-20-00125-b10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/MCG.0b013e3182a87cfd","article-title":"A systematic review of sorafenib in Child-Pugh A patients with unresectable hepatocellular carcinoma","volume":"47","author":"Shen","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"key20210307230651_JCTH-D-20-00125-b11","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20210307230651_JCTH-D-20-00125-b12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12885-017-3545-5","article-title":"The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B\/C hepatocellular carcinoma","volume":"17","author":"Wu","year":"2017","journal-title":"BMC Cancer"},{"key":"key20210307230651_JCTH-D-20-00125-b13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrclinonc.2009.114","article-title":"Targeted therapies: Role of sorafenib in HCC patients with compromised liver function","volume":"6","author":"Di Maio","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"key20210307230651_JCTH-D-20-00125-b14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1526924816664083","article-title":"Role of sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation","volume":"26","author":"de\u2019Angelis","year":"2016","journal-title":"Prog Transplant"},{"key":"key20210307230651_JCTH-D-20-00125-b15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20210307230651_JCTH-D-20-00125-b16","first-page":"754","article-title":"Effect of radiofrequency ablation combined with sorafenib on liver function in patients with advanced hepatic carcinoma","volume":"16","author":"Yu","year":"2018","journal-title":"Chinese Journal of General Practice"},{"key":"key20210307230651_JCTH-D-20-00125-b17","first-page":"714","article-title":"Analysis on efficacy and prognostic factors of radiofrequency ablation combined with sorafenib in the treatment of advanced hepatocellular carcinoma","volume":"49","author":"Fu","year":"2020","journal-title":"Chongqing Yixue"},{"key":"key20210307230651_JCTH-D-20-00125-b18","first-page":"247","article-title":"Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma","volume":"19","author":"Kan","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20210307230651_JCTH-D-20-00125-b19","first-page":"409","article-title":"Radiofrequency ablation plus sorafenib for hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2015","journal-title":"J Chin Pract Diagn Ther"},{"key":"key20210307230651_JCTH-D-20-00125-b20","first-page":"688","article-title":"Effect of radiofrequency ablation combined with sorafenib in treating primary hepatocellular carcinoma","volume":"11","author":"Wu","year":"2016","journal-title":"Chinese medicine"},{"key":"key20210307230651_JCTH-D-20-00125-b21","first-page":"7045","article-title":"Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation","volume":"14","author":"Gong","year":"2017","journal-title":"Oncol Lett"},{"key":"key20210307230651_JCTH-D-20-00125-b22","first-page":"1093","article-title":"Clinical study of radiofrequency ablation therapy in combination with sorafenib for advanced hepatocellular carcinoma","volume":"27","author":"Sun","year":"2011","journal-title":"J Clini Hepatol"},{"key":"key20210307230651_JCTH-D-20-00125-b23","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/ajg.2014.343","article-title":"Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study","volume":"109","author":"Feng","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"key20210307230651_JCTH-D-20-00125-b24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1148\/radiol.14131640","article-title":"Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation\u2014propensity score matching analysis","volume":"272","author":"Fukuda","year":"2014","journal-title":"Radiology"},{"key":"key20210307230651_JCTH-D-20-00125-b25","first-page":"10","article-title":"Clinical study of radiofrequency ablation therapy and sorafenib for hepatocellular carcinoma","volume":"35","author":"Li","year":"2014","journal-title":"Journal of Medical Forum"},{"key":"key20210307230651_JCTH-D-20-00125-b26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1148\/radiol.2018172028","article-title":"Medium or large hepatocellular carcinoma: Sorafenib combined with transarterial chemoembolization and radiofrequency ablation","volume":"288","author":"Zhu","year":"2018","journal-title":"Radiology"},{"key":"key20210307230651_JCTH-D-20-00125-b27","first-page":"790","article-title":"Therapeutic effects of sorafenib combined with transcatheter arterial chemoembolization and microwave ablation on postsurgical recurrent hepatocellular carcinoma","volume":"34","author":"Hua","year":"2012","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20210307230651_JCTH-D-20-00125-b28","first-page":"291","article-title":"Therapeutic effects of sorafenib combined with transcatheter arterial chemoembolization and microwave ablation on postsurgical recurrent hepatocellular carcinoma","volume":"18","author":"Zheng","year":"2013","journal-title":"Chinese Hepatology"},{"key":"key20210307230651_JCTH-D-20-00125-b29","first-page":"664","article-title":"Effect of microwave ablation combined with sorafenib in the treatment of primary liver cancer","volume":"33","author":"Sun","year":"2018","journal-title":"The Practical Journal of Cancer"},{"key":"key20210307230651_JCTH-D-20-00125-b30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00270-014-0895-0","article-title":"Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer","volume":"38","author":"Wei","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"key20210307230651_JCTH-D-20-00125-b31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4103\/0973-1482.150405","article-title":"Sorafenib combined with radiofrequency ablation in the treatment of a patient with renal cell carcinoma plus primary hepatocellular carcinoma","volume":"11","author":"Gang","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"key20210307230651_JCTH-D-20-00125-b32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11605-007-0100-8","article-title":"Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis","volume":"11","author":"White","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"key20210307230651_JCTH-D-20-00125-b33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11605-008-0727-0","article-title":"Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?","volume":"13","author":"Reuter","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"key20210307230651_JCTH-D-20-00125-b34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1634\/theoncologist.2008-0131","article-title":"Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib","volume":"13","author":"Lacouture","year":"2008","journal-title":"Oncologist"},{"key":"key20210307230651_JCTH-D-20-00125-b35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/annonc\/mdr525","article-title":"Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications","volume":"23","author":"Mir","year":"2012","journal-title":"Ann Oncol"},{"key":"key20210307230651_JCTH-D-20-00125-b36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000342425","article-title":"Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma","volume":"84","author":"Koschny","year":"2013","journal-title":"Oncology"},{"key":"key20210307230651_JCTH-D-20-00125-b37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2014.03.030","article-title":"Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib","volume":"61","author":"Reig","year":"2014","journal-title":"J Hepatol"},{"key":"key20210307230651_JCTH-D-20-00125-b38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2893.2009.01117.x","article-title":"Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden","volume":"16","author":"Nguyen","year":"2009","journal-title":"J Viral Hepat"},{"key":"key20210307230651_JCTH-D-20-00125-b39","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"key20210307230651_JCTH-D-20-00125-b40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc1112501","article-title":"Hepatocellular carcinoma","volume":"366","author":"Tsochatzis","year":"2012","journal-title":"N Engl J Med"},{"key":"key20210307230651_JCTH-D-20-00125-b41","first-page":"1525","article-title":"Sorafenib combined with radiofrequency ablation as treatment for patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"22","author":"Chen","year":"2017","journal-title":"J BUON"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2020-00125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:43Z","timestamp":1783707583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2020-00125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":41,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2021,3,8]]}},"alternative-id":["10.14218\/JCTH.2020.00125"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2020.00125","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}